Skye Bioscience Inc. Alternatives & Competitors
12 companies similar to Skye Bioscience Inc. — Unlocking new therapeutic pathways for metabolic health
Companies similar to Skye Bioscience Inc.
Celltrion Inc
Built on Trust, Toward Innovation
Ipsen
Engineers and develops bacterial-based protein therapeutics for the treatment of neurologi...
Sangamo Therapeutics, Inc.
We're committed to translating our ground-breaking science into genomic medicines that tra...
BlossomHill Therapeutics, Inc.
Addressing urgent unmet medical needs through deeper science, true originality, and rich e...
Rival Readout
Competing with Skye Bioscience Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Septerna
Bringing a new era of GPCR medicines to patients with its Native Complex Platform™.
AdipoPharma SAS
French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabete...
ImmunoMet Therapeutics, Inc.
Targeting Metabolic Reprogramming in Fibrosis and Oncology
AusperBio
Transforming Patient Lives For a Better Tomorrow
uniQure
Transforming the lives of patients through gene therapy
Xeno Biosciences
Gastric Bypass in a Pill
Vial
Vial is a next-gen pharma company advancing best-in-class biologics and RNA therapeutics a...
Corteria Pharmaceuticals
Interceptive therapies for the treatment of heart failure subpopulations
About Skye Bioscience Inc.
Skye Bioscience Inc. is a pioneering company in the biotechnology and pharmaceutical industries, headquartered in the United States. Founded in 2011, the company is committed to "unlocking new therapeutic pathways for metabolic health," emphasizing novel treatments for metabolic conditions.
Development of next-generation drugs, Research and development in metabolic health, Clinical trial execution, Exploration of therapeutic mechanisms, Drug manufacturing and regulatory compliance
Patients with obesity, Healthcare providers, Medical researchers, Pharmaceutical industry partners, Investors interested in biotech and metabolic health
Metabolic Health, G-Protein Coupled Receptors, Therapeutic Pathways, Nimacimab, CB1 Inhibition, Negative Allosteric Modulation, Obesity Treatment, Clinical Trials, Biologic Targets, First-in-Class Therapeutics, Inflammatory Conditions, Fibrotic Diseases, Pharmaceutical Development, GLP-1R Agonist Combination, Proprietary Molecules
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Skye Bioscience Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Skye Bioscience Inc. on 20 Mar 2026. The 12 companies listed here were last checked between 7 Jun 2025 and 8 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.